" For years , a large segment of the U . S . population has been anxiously awaiting a bold new breakthrough in self administered mood enhancing substances , " chief developer Dr Stanley Kupferman said . " With Dexiflux V , that long anticipated day has finally arrived . In clinical trials , we administered Dexiflux V to over 1 , 600 people , and , in virtually every case , the test subject reported being stoned out of his or her freaking gourd . "
